These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4189483)

  • 1. Palliative treatment of metastasized breast cancer with 5-FU in slow intravenous infusion.
    Huys J; Van Vaerenbergh PM
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):775-80. PubMed ID: 4189483
    [No Abstract]   [Full Text] [Related]  

  • 2. Palliative treatment of metastasized breast cancer with 5-fluoro-uracil in slow intravenous infusion.
    Huys J; Van Vaerenbergh PM
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):805-6. PubMed ID: 4173581
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
    Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
    J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A safe and effective method of administering 5-fluorouracil to adrenalectomized patients.
    Hall TC; Wilson RE
    Surg Gynecol Obstet; 1966 Nov; 123(5):978-82. PubMed ID: 4162748
    [No Abstract]   [Full Text] [Related]  

  • 5. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged 5-fluorouracil infusion in patients with metastatic colon cancer pretreated with bolus schedule of the same agent.
    Tralongo P; Di Mari A; Scibilia G; Bosco V; Giudice A; Respini D; Failla G
    Anticancer Res; 1995; 15(2):635-8. PubMed ID: 7539242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic breast cancer by navelbine, mitoxantrone and continuous infusion 5-fluorouracil (FMN regimen): results of a pilot study.
    Azim HA
    J Infus Chemother; 1996; 6(2):102-6. PubMed ID: 8809659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of terminal cancer and relapsed cancer by 5-5-FU(5-fluorouracil)].
    Uemura T; Amba T; Hamada M; Tanaka S
    Gan No Rinsho; 1968 Jul; 14(7):553-6. PubMed ID: 4177873
    [No Abstract]   [Full Text] [Related]  

  • 9. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential methotrexate and 5-FU in breast cancer resistant to the conventional application of these drugs.
    Herrmann R; Manegold C; Schroeder M; Tigges FJ; Bartsch H; Jungi F; Fritze D
    Cancer Treat Rep; 1984 Oct; 68(10):1279-81. PubMed ID: 6525599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.
    Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ
    Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
    Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose intravenous infusions of 5-fluorouracil for refractory solid tumours-the HI-FU regimen.
    Spiers AS; Kasimis BS; Janis MG
    Clin Oncol; 1980 Mar; 6(1):63-9. PubMed ID: 6154557
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U; Harstrick A; Wilke H; Seeber S
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer.
    Closon MT; Verbeke L; Kains JP; Tijtgat J; Schallier D
    Anticancer Res; 1995; 15(2):591-5. PubMed ID: 7539240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Principles and technics of continuous arterial infusion of 5-fluorouracil in carcinoma of the breast in advanced stage: results in 15 cases].
    Salvadori B; Gennari L
    Chir Ital; 1967 Aug; 19(4):420-38. PubMed ID: 4176450
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of advanced tumors with 5-fluoro-uracil].
    Zimmermann G; Boeckl O
    Wien Med Wochenschr; 1969 Sep; 119(37):613-6. PubMed ID: 4187496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.